A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
Clinical trial NCT07317700 · RECRUITING
Trial details
- NCT number
- NCT07317700
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-13
- Primary completion
- 2027-12-30
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.